Guardant Health
GH
#3091
Rank
$4.03 B
Marketcap
$32.65
Share price
5.39%
Change (1 day)
34.97%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2024 (TTM): -$0.5 Billion USD

According to Guardant Health 's latest financial reports the company's current earnings are $0.64 Billion USD. In 2023 the company made an earning of -$0.48 Billion USD, an increase over its 2022 earnings that were of -$0.66 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -$0.5 Billion2.4%
2023 -$0.48 Billion-26.73%
2022 -$0.66 Billion69.96%
2021 -$0.39 Billion56.35%
2020 -$0.25 Billion252.69%
2019 -$69.73 Million-17.22%
2018 -$84.23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-$0.3 Billion-40.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-$31.58 Million-93.56%๐Ÿ‡บ๐Ÿ‡ธ USA